Alkermes (ALKS) EBT Margin (2010 - 2026)
Alkermes' (ALKS) quarterly EBT Margin came in at 15.76% in Q1 2026, down 2408.0% year-on-year from 0.68% in Q1 2025, and down 200.38% on a QoQ basis from 15.7% in Q4 2025.
Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of EBT Margin data on file, last reported at 15.76% in Q1 2026.
- On a quarterly basis, EBT Margin fell 2408.0% year-over-year to 15.76% in Q1 2026; TTM through Mar 2026 was 13.06%, a 1484.0% decrease from a year earlier, with the FY2025 full-year figure at 19.75%, down 874.0% from the prior year.
- EBT Margin for Q1 2026 stood at 15.76%, down from 15.7% in the prior quarter.
- Over the last five years, EBT Margin for ALKS reached as high as 45.65% in Q2 2023 and fell as low as 2105.25% in Q3 2022.
- Historically, EBT Margin has averaged 168.79% across 5 years, with a median of 15.7% in 2025.
- Across the five-year window, EBT Margin sank 209623 bps in 2022 and jumped 212959 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 37.58% in 2022, then sank by 59 bps to 15.45% in 2023, then soared by 156 bps to 39.51% in 2024, then sank by 60 bps to 15.7% in 2025, then sank by 200 bps to 15.76% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 15.76% in Q1 2026, 15.7% in Q4 2025, and 25.56% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -15.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.76% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | 25.56% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 39.51% |
| Sep 30, 2024 | 29.15% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 13.39% |
| Dec 31, 2023 | 15.45% |
| Sep 30, 2023 | 24.34% |
| Jun 30, 2023 | 45.65% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | 37.58% |
| Sep 30, 2022 | -2,105.25% |
| Jun 30, 2022 | -1,039.06% |
| Mar 31, 2022 | -16.15% |
| Dec 31, 2021 | 39.22% |
| Sep 30, 2021 | -9.02% |
| Jun 30, 2021 | 1.86% |